U.S. RESEARCH ROUNDUP- Apellis Pharmaceuticals, Energizer Holdings, Walmart

Labcorp Holdings

20/11/2024 06:56

Nov 20 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Apellis Pharmaceuticals, Energizer Holdings
and Walmart on Wednesday. 
    
      HIGHLIGHTS       
  
     
                 * Apellis Pharmaceuticals Inc  APLS.O : JP Morgan cuts target price to $50 from
 $57
 
                 * Chord Energy Corp  CHRD.O : RBC cuts target price to $180 from $185
 
                 * Energizer Holdings Inc  ENR.N : JP Morgan raises to neutral from underweight 
 
                 * Salesforce Inc  CRM.N : JP Morgan raises target price to $340 from $310
 
                 * Walmart  WMT.N : Telsey Advisory Group raises target price to $100 from $92
 
                
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday.
Stock entries are in alphabetical order.         

                 * Aerovironment Inc  AVAV.O : Jefferies cuts target price to $230 from $240
 
                 * Aerovironment Inc  AVAV.O : Jefferies raises to buy from hold
 
                 * Annexon Inc  ANNX.O : JP Morgan cuts target price to $9 from $11
 
                 * Apellis Pharmaceuticals Inc  APLS.O : JP Morgan cuts target price to $50 from $57
 
                 * Arbutus Biopharma Corp  ABUS.O : Chardan Capital Markets raises PT to $5 from
 $4.5
 
                 * Azek Company Inc  AZEK.N : RBC raises target price to $50 from $46
 
                 * Bellring Brands Inc  BRBR.N : JP Morgan raises target price to $84 from $64
 
                 * Berry Global Group Inc  BERY.N : Baird raises target price to $70 from $65
 
                 * Bridgebio pharma Inc  BBIO.O : JP Morgan cuts target price to $40 from $43
 
                 * Caseys General Stores Inc  CASY.O : JP Morgan raises target price to $338 from
 $337
 
                 * Chord Energy Corp  CHRD.O : RBC cuts target price to $180 from $185
 
                 * Dyne Therapeutics  DYN.O : JP Morgan cuts target price to $34 from $35
 
                 * Energizer Holdings Inc  ENR.N : JP Morgan raises target price to $39 from $32
 
                 * Energizer Holdings Inc  ENR.N : JP Morgan raises to neutral from underweight 
 
                 * Firstsun Capital Bancorp  FSUN.O : Raymond James raises to outperform from market
 perform
 
                 * I3 Verticals Inc  IIIV.O : Raymond James raises target price to $30 from $28
 
                 * Labcorp  LH.N : Mizuho raises target price to $264 from $256
 
                 * Lowe's Companies Inc  LOW.N : HSBC raises target price to $262 from $260
 
                 * Lowe's Companies Inc  LOW.N : Jefferies raises target price to $301 from $274
 
                 * Lowe's Companies Inc  LOW.N : RBC raises target price to $291 from $290
 
                 * Monopar Therapeutics Inc  MNPR.O : Jonestrading raises target price to $37 from
 $9
 
                 * Northern Oil and Gas Inc  NOG.N : RBC cuts to sector perform from outperform 
 
                 * Northern Oil and Gas Inc  NOG.N : RBC raises target price to $45 from $43
 
                 * Nuvalent Inc  NUVL.O : JP Morgan cuts target price to $121 from $125
 
                 * Oaktree Specialty Lending Corp  OCSL.O : JP Morgan cuts PT to $15 from $17
 
                 * Oaktree Specialty Lending Corp  OCSL.O : JP Morgan cuts to neutral from
 overweight 
 
                 * Oaktree Specialty Lending Corp  OCSL.O : KBW cuts target price to $17 from $18
 
                 * Olema Pharmaceuticals Inc  OLMA.O : JP Morgan cuts target price to $29 from $31
 
                 * P3 Health Partners Inc  PIII.O : TD Cowen cuts target price to $0.25 from $0.90
 
                 * PBF Energy Inc  PBF.N : JP Morgan cuts target price to $37 from $40
 
                 * Salesforce Inc  CRM.N : JP Morgan raises target price to $340 from $310
 
                 * Springworks Therapeutics Inc  SWTX.O : JP Morgan raises target price to $70 from
 $68
 
                 * Travere Therapeutics Inc  TVTX.O : JP Morgan cuts target price to $42 from $43
 
                 * Valvoline Inc  VVV.N : JP Morgan cuts target price to $37 from $40
 
                 * Valvoline Inc  VVV.N : RBC cuts target price to $46 from $52
 
                 * Vera Therapeutics Inc  VERA.O : JP Morgan raises target price to $77 from $75
 
                 * Vir Biotechnology Inc  VIR.O : JP Morgan cuts target price to $10 from $13
 
                 * Walmart  WMT.N : Jefferies raises target price to $105 from $100
 
                 * Walmart  WMT.N : RBC raises target price to $96 from $92
 
                 * Walmart  WMT.N : Telsey Advisory Group raises target price to $100 from $92
 
                    
    

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))